Clearside Biomedical Names Charles Deignan Chief Financial Officer
10/29/2012 6:29:32 AM
ATLANTA---Clearside Biomedical Inc., an ophthalmic pharmaceutical company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, announced today that Charles Deignan has been named to the position of Chief Financial Officer. Deignan will report to Daniel White, President and CEO.